Rare melanoma research powered by Illumina Protein Prep

Proteomics provides a powerful, non-invasive way to explore cancer biology. Assistant Professor Kacey Couts and her team at the University of Colorado are using Illumina Protein Prep to uncover novel insights into rare melanomas. This assay identifies 9.5K unique human proteins across more than 200 biological pathways, enabling her team to maximize discovery power as they search for novel biomarkers and investigate treatment responses.

Learn more about Illumina Protein Prep here: https://www.illumina.com/products/by-...

Learn how proteomics as part of a multiomics workflow can boost discovery power: https://www.illumina.com/techniques/m...

Subscribe to the Illumina video channel http://www.youtube.com/subscription_c...

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.

View customer spotlight videos
   • Illumina Customer Testimonials  

View Illumina webinars
   • Webinars  

View Illumina support videos
   • Illumina Support  

LinkedIn:   / illumina  
X: https://x.com/illumina
Instagram:   / illuminainc  
Facebook:   / illuminainc  
TikTok:   / illuminainc  

#Illumina #IlluminaProteinPrep #NovaSeq